Skip to content
Longterm Wiki
Back

Cause IQ — Blueprint Biosecurity 990

web

This is a nonprofit financial/organizational profile page relevant to biosecurity and pandemic preparedness; tangentially related to AI safety insofar as biosecurity overlaps with broad catastrophic risk reduction priorities in the EA and existential risk communities.

Metadata

Importance: 18/100organizational reportreference

Summary

Blueprint Biosecurity is a Washington DC-based nonprofit (founded 2023) focused on pandemic prevention through Far-UVC technology, built environment transmission suppression, PPE stockpiling, and biosecurity policy advocacy. The organization had ~$1.8M in revenues and ~$3.1M in expenses in 2024 with 10 employees. It operates as a subordinate of Mirror Biology Dialogues Fund.

Key Points

  • Promotes Far-UVC technology to reduce airborne pathogen transmission, pursuing expert consensus and public health body endorsements.
  • Runs a Built Environment Transmission Suppression (BETS) program evaluating interventions like glycol-based pathogen suppression.
  • Advocates for advanced PPE stockpiling and manufacturing of reusable respirators to address global respiratory protection shortfalls.
  • Engages in biosecurity stakeholder education, strategic planning, and government affairs to strengthen pandemic preparedness frameworks.
  • Granted $12,500 to Johns Hopkins Center for Health Security for a Far-UVC workshop in 2024.

Cited by 1 page

PageTypeQuality
Blueprint BiosecurityOrganization60.0

Cached Content Preview

HTTP 200Fetched Mar 20, 202612 KB
1. [Directory](https://www.causeiq.com/directory/)
2. [District of Columbia](https://www.causeiq.com/directory/district-of-columbia-state/)
3. [Washington](https://www.causeiq.com/directory/washington-arlington-alexandria-dc-va-md-wv-metro/)
4. Blueprint Biosecurity

EIN 93-2385426

# Blueprint Biosecurity

[Programs](https://www.causeiq.com/organizations/blueprint-biosecurity,932385426/#programs)\|[Grantmaking](https://www.causeiq.com/organizations/blueprint-biosecurity,932385426/#grantmaking)\|[Funding](https://www.causeiq.com/organizations/blueprint-biosecurity,932385426/#funding)\|[Personnel](https://www.causeiq.com/organizations/blueprint-biosecurity,932385426/#personnel)\|[Financials](https://www.causeiq.com/organizations/blueprint-biosecurity,932385426/#financials)\|[Form 990s](https://www.causeiq.com/organizations/blueprint-biosecurity,932385426/#form990s)\|[Peers](https://www.causeiq.com/organizations/blueprint-biosecurity,932385426/#similar)

IRS 501(c) type

501(c)(3)

Num. employees

10

City

[Washington](https://www.causeiq.com/directory/washington-arlington-alexandria-dc-va-md-wv-metro/)

State

[District of Columbia](https://www.causeiq.com/directory/district-of-columbia-state/)

Year formed

2023

Most recent tax filings

2024-12-01

NTEE code, primary

[M00: Public Safety, Disaster Preparedness, and Relief: General](https://www.causeiq.com/directory/public-safety-organizations-list/)

Description

Blueprint Biosecurity advances pandemic prevention through innovative planning, stakeholder engagement, and initiatives, focusing on Far-UVC technology to mitigate infectious pathogen risks.

Related structure

Blueprint Biosecurity is a subordinate organization under [Mirror Biology Dialogues Fund](https://www.causeiq.com/organizations/initiative-on-frontier-biotechnology,993886393/).

Total revenues

$1,832,186

2024

20232024$1m$2m$3m

Total expenses

$3,095,622

2024

20232024$0$2m$4m

Total assets

$819,848

2024

20232024$0$2m

Num. employees

10

2024

202320240510

## Program areas at Blueprint Biosecurity

Far-uvc - the far-uvc program aims to accelerate widespread adoption of this breakthrough technology. The program advances the highest priority safety, efficacy, and real-world effectiveness studies, with the ultimate goals of fostering expert consensus, securing endorsements from trusted public health bodies, developing real-world implementation guidance, and catalyzing large-scale adoption.

Built environment transmission suppression (bets) - the organization's research team evaluates interventions for suppressing transmission of airborne pathogens, such as glycols. They conduct desktop research, interview leading experts across a range of fields, write reports, and suggest ways to advance the development of the most promising opportunities.

Biosecurity, pandemic prevention, and government affairs - the organization mitigates pandemic risk through comprehensive stakeholder education, strategic planning, and collaborative 

... (truncated, 12 KB total)
Resource ID: 36b2de551829de87 | Stable ID: YzQzOTUyMz